In patients with resectable non-small cell lung cancer, the ratio of CD66b+ tumor-infiltrating neutrophils (TINs) to CD8+ T cells is reported as an independent prognostic factor for high tumor recurrence and poor overall survival (306). The gene discussed is CD8A; the disease is neoplasm.